These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32945503)

  • 21. PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.
    He S; Ma X; Zheng N; Wang G; Wang M; Xia W; Yu D
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
    He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma.
    Hu L; Chen J; Zhang F; Wang J; Pan J; Chen J; Wang Y
    Biomed Res Int; 2017; 2017():7498151. PubMed ID: 29279851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and significance of IKBKB in pulmonary adenocarcinoma A549 cells and its cisplatin-resistant variant A549/DDP].
    Qi K; Li Y; Li X; Zhang F; Shao Y; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2014 May; 17(5):363-8. PubMed ID: 24854552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation.
    Yang L; Luo P; Song Q; Fei X
    Biomed Pharmacother; 2018 Mar; 99():839-847. PubMed ID: 29710483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression.
    Liu Z; Sun M; Lu K; Liu J; Zhang M; Wu W; De W; Wang Z; Wang R
    PLoS One; 2013; 8(10):e77293. PubMed ID: 24155936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line.
    Li A; Song J; Lai Q; Liu B; Wang H; Xu Y; Feng X; Sun X; Du Z
    Int J Exp Pathol; 2016 Dec; 97(6):412-421. PubMed ID: 27995666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis.
    Zheng F; Xu R
    Biomed Pharmacother; 2020 Apr; 124():109828. PubMed ID: 31986409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
    Cao L; Zhou X; Ding X; Gao D
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells.
    Xu M; Tang X; Guo J; Sun W; Tang F
    Oncol Rep; 2017 Nov; 38(5):2843-2851. PubMed ID: 29048638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silence of  lncRNA UCA1 rescues drug resistance of cisplatin to non-small-cell lung cancer cells.
    Liu X; Huang Z; Qian W; Zhang Q; Sun J
    J Cell Biochem; 2019 Jun; 120(6):9243-9249. PubMed ID: 30652341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baicalin attenuates DDP (cisplatin) resistance in lung cancer by downregulating MARK2 and p-Akt.
    Xu Z; Mei J; Tan Y
    Int J Oncol; 2017 Jan; 50(1):93-100. PubMed ID: 27878245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOXA10 promotion of HDAC1 underpins the development of lung adenocarcinoma through the DNMT1-KLF4 axis.
    Ma T; Yan B; Hu Y; Zhang Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):71. PubMed ID: 33596966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance.
    Ma Q; Li P; Xu M; Yin J; Su Z; Li W; Zhang J
    J Exp Clin Cancer Res; 2012 Nov; 31(1):99. PubMed ID: 23181744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
    Qi MM; Ge F; Chen XJ; Tang C; Ma J
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
    Du H; Li Y; Sun R; Yuan Y; Sun S; Zhang Y
    Thorac Cancer; 2020 Sep; 11(9):2473-2482. PubMed ID: 32648688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.